Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy
Clinical trial NCT04973319 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04973319
- Sponsor
- Shengjing Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.